Acute kidney injury is followed by regeneration of damaged renal tubular epithelial cells.
The purpose of this study was to test the hypothesis that renal stem cells exist in the adult …

Background Patients on hemodialysis have an elevated risk for COVID-19 but were not
included in efficacy trials of SARS-CoV-2 vaccines. Methods We conducted a retrospective, …

Results Daprodustat three times weekly was noninferior to epoetin for mean change in
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],− 0.05; 95% …

To better understand the implications for considering delayed graft function (DGF) as a
performance measure, we compared outcomes associated with a 2- to 3-fold difference in the …

Introduction Patiromer is a potassium (K + ) binding polymer indicated for treating hyperkalemia.
Among patients receiving chronic hemodialysis (HD), this study aimed to identify patient …

Background Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is rare among individuals with few coronavirus disease 2019 (COVID-19) risk …

Background Studies have demonstrated that mRNA-based SARS-CoV-2 vaccines are highly
effective among patients on dialysis. Because individual vaccines may be differentially …

Background Hemodialysis patients are at increased risk of hepatitis B virus (HBV) infection
and are poorly responsive to HBV vaccines. Current vaccine recommendations for …

The mass balance, pharmacokinetics, and biotransformation of JTZ‐951 (enarodustat), a
novel hypoxia‐inducible factor prolyl hydroxylase inhibitor, were characterized in patients (N = …

Introduction Chronic kidney disease (CKD) has a prevalence of 9.1% globally, and frequently
results in elevated serum phosphate, increasing cardiovascular morbidity and mortality risk …